Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients

Clinical trial NCT01672463 · UNKNOWN

Trial details

NCT number: NCT01672463
Sponsor: Oblato, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Malignant Glioma

Start date: 2012-12-01
Primary completion: 2023-01-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.